Amphastar Pharmaceuticals, Inc. (AMPH): Price and Financial Metrics

Amphastar Pharmaceuticals, Inc. (AMPH): $46.22

0.23 (+0.50%)

POWR Rating

Component Grades








Add AMPH to Watchlist
Sign Up

AMPH Price/Volume Stats

Current price $46.22 52-week high $67.66
Prev. close $45.99 52-week low $26.76
Day low $45.79 Volume 41,195
Day high $46.36 Avg. volume 393,257
50-day MA $53.43 Dividend yield N/A
200-day MA $43.03 Market Cap 2.23B

AMPH Stock Price Chart Interactive Chart >


  • Growth is the dimension where AMPH ranks best; there it ranks ahead of 93.01% of US stocks.
  • The strongest trend for AMPH is in Growth, which has been heading up over the past 177 days.
  • AMPH's current lowest rank is in the Momentum metric (where it is better than 9.63% of US stocks).

AMPH Stock Summary

  • With a one year PEG ratio of 139.16, AMPHASTAR PHARMACEUTICALS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 81.1% of US stocks.
  • With a year-over-year growth in debt of 408.78%, AMPHASTAR PHARMACEUTICALS INC's debt growth rate surpasses 97.11% of about US stocks.
  • The volatility of AMPHASTAR PHARMACEUTICALS INC's share price is greater than that of 80.51% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to AMPHASTAR PHARMACEUTICALS INC are AGYS, ALRM, MIRM, SDGR, and ALGM.
  • AMPH's SEC filings can be seen here. And to visit AMPHASTAR PHARMACEUTICALS INC's official web site, go to

AMPH Valuation Summary

  • AMPH's EV/EBIT ratio is 19.4; this is 67.24% higher than that of the median Healthcare stock.
  • AMPH's price/earnings ratio has moved down 25.8 over the prior 113 months.

Below are key valuation metrics over time for AMPH.

Stock Date P/S P/B P/E EV/EBIT
AMPH 2023-09-22 4.1 3.8 21.8 19.4
AMPH 2023-09-21 4.1 3.8 21.9 19.5
AMPH 2023-09-20 4.2 3.8 22.1 19.7
AMPH 2023-09-19 4.2 3.8 22.1 19.6
AMPH 2023-09-18 4.2 3.8 22.2 19.7
AMPH 2023-09-15 4.1 3.8 21.9 19.5

AMPH Growth Metrics

    The 3 year net cashflow from operations growth rate now stands at 380.28%.
  • Its 5 year cash and equivalents growth rate is now at -26.13%.
  • The 5 year price growth rate now stands at 26.94%.
Over the past 67 months, AMPH's revenue has gone up $232,382,000.

The table below shows AMPH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 484.851 114.396 77.233
2022-06-30 476.92 96.59 90.907
2022-03-31 455.116 125.934 81.328
2021-12-31 437.768 97.994 62.116
2021-09-30 412.802 74.446 36.083
2021-06-30 384.035 80.684 10.454

AMPH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AMPH has a Quality Grade of C, ranking ahead of 66.19% of graded US stocks.
  • AMPH's asset turnover comes in at 0.601 -- ranking 59th of 680 Pharmaceutical Products stocks.
  • VTVT, MTEX, and BBI are the stocks whose asset turnover ratios are most correlated with AMPH.

The table below shows AMPH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.601 0.431 0.042
2021-03-31 0.591 0.411 0.012
2020-12-31 0.579 0.410 0.012
2020-09-30 0.568 0.415 0.026
2020-06-30 0.570 0.415 0.017
2020-03-31 0.558 0.421 0.160

AMPH Price Target

For more insight on analysts targets of AMPH, see our AMPH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $22.75 Average Broker Recommendation 1.75 (Moderate Buy)

Amphastar Pharmaceuticals, Inc. (AMPH) Company Bio

Amphastar Pharmaceuticals focuses on the development, manufacture, marketing, and sale of generic and proprietary injectable and inhalation products. It operates in two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients. The company was founded in 1996 and is based in Rancho Cucamonga, California.

AMPH Latest News Stream

Event/Time News Detail
Loading, please wait...

AMPH Latest Social Stream

Loading social stream, please wait...

View Full AMPH Social Stream

Latest AMPH News From Around the Web

Below are the latest news stories about AMPHASTAR PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMPH as an investment opportunity.

The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks

The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.

Yahoo | September 29, 2023

Amphastar Pharmaceuticals (AMPH) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Amphastar Pharmaceuticals (AMPH) closed at $45.88, marking a +0.81% move from the previous day.

Yahoo | September 25, 2023

Amphastar Pharmaceuticals (AMPH) Dips More Than Broader Markets: What You Should Know

Amphastar Pharmaceuticals (AMPH) closed the most recent trading day at $46.04, moving -0.41% from the previous trading session.

Yahoo | September 19, 2023

Is There An Opportunity With Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) 46% Undervaluation?

Key Insights Amphastar Pharmaceuticals' estimated fair value is US$84.33 based on 2 Stage Free Cash Flow to Equity...

Yahoo | September 18, 2023

Should You Invest in Amphastar (AMPH) Based on Bullish Wall Street Views?

Based on the average brokerage recommendation (ABR), Amphastar (AMPH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Yahoo | September 14, 2023

Read More 'AMPH' Stories Here

AMPH Price Returns

1-mo -15.24%
3-mo N/A
6-mo 18.70%
1-year 64.48%
3-year 143.26%
5-year 140.10%
YTD 64.95%
2022 20.31%
2021 15.81%
2020 4.25%
2019 -3.07%
2018 3.43%

Continue Researching AMPH

Want to see what other sources are saying about Amphastar Pharmaceuticals Inc's financials and stock price? Try the links below:

Amphastar Pharmaceuticals Inc (AMPH) Stock Price | Nasdaq
Amphastar Pharmaceuticals Inc (AMPH) Stock Quote, History and News - Yahoo Finance
Amphastar Pharmaceuticals Inc (AMPH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!